MM.............please again ........show me "where" it states that " their is more lab testing still to be done. [your quote] in the Announcement shown below?
13/05/2020 HPA PFS UPDATE
As reported in KRR ASX release 23 April 2020, further hydrometallurgical work has continued to be
undertaken for our HPA PFS to be finalised on completion of the following tests, including:
• repeating the previously reported 4N HPA product test on a larger sample to repeat the >99.99% result
and provide additional product for verification analyses;
• an independent umpire assay of our >99.99% Al2O3 result (KRR ASX release 23 April 2020);
• new equipment trials to increase the calcination temperature to ensure the HPA phase is all alpha alumina;
• confirm our HPA is 100% alpha-alumina by an X-Ray Diffraction (XRD) analysis;
• increase the Stage 2 purification efficiency.
The last Announcement [HPA PFS UPDATE ] & a previous Announcement KRR ASX Release 23 April 2020 have all covered the work being undertaken at that time.
No where does it STATE..........".their is more lab testing still to be done" as you keep suggesting which is wrong!
As I asked ..........show me where it states there is MORE testing to be done!
Again see below -
As reported in KRR ASX release 23 April 2020, further hydrometallurgical work has continued to be
undertaken for our HPA PFS to be finalised on completion of the following tests, including:
This states the work has been continued to be carried out [completed] from the period of the previous Announcement [23 April] until the current Announcement [13 May]
and NOTHING ELSE! It does not sugggest there is more testing nor is there mention of continuing, or extra testing to be done from this Announcement [13 May].
Yak52
- Forums
- ASX - By Stock
- KRR
- KRR stock price
KRR stock price, page-92
-
- There are more pages in this discussion • 161 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KRR (ASX) to my watchlist
|
|||||
Last
1.3¢ |
Change
0.001(4.17%) |
Mkt cap ! $19.10M |
Open | High | Low | Value | Volume |
1.2¢ | 1.3¢ | 1.2¢ | $541 | 44.93K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 922313 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 1291765 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 922313 | 0.012 |
5 | 1108376 | 0.011 |
15 | 1366126 | 0.010 |
18 | 5316073 | 0.009 |
6 | 27085928 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 1291765 | 5 |
0.014 | 2384315 | 6 |
0.015 | 4223336 | 7 |
0.016 | 1538409 | 6 |
0.018 | 2215474 | 3 |
Last trade - 10.36am 13/08/2024 (20 minute delay) ? |
Featured News
KRR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online